Skip to content
Research Article Open access CC BY 4.0

Prevalence, Risk Factors, and Management of Stroke in Patients with COVID-19 Infection: A Review

Sidra Shahid Mubasher, Humera Batool, Emen Udo Kierian, Khatja Batool

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 10–17 · Published 27 Sep 2021

10.9734/jamps/2021/v23i730245

Abstract

In the current pandemic, it is imperative to comprehend and advance a search forward to explore the pathogenesis of stroke in COVID-19 infected patients. In this review, we have discussed the prevalence of stroke in COVID-19 infected patients and different risk factors associated with the stroke in COVID-19. We also presented a comprehensive review on management of Stroke Patients during the COVID-19 pandemic. The COVID-19 positive patients with stroke should be treated in a designated COVID-19 health care center as per the guidelines. Study also showed that older patients with a history of cardiovascular diseases, prothrombotic state, smoking, and infection significantly had a higher likelihood of stroke incidence. The study revealed that effective treatment of COVID-19 and reduction of the inflammatory conditions may seem to be the way forward to minimize the symptomatic stroke associated with COVID-19 infection, and rehabilitation of Stroke patients should be optimal during a pandemic.

Coronavirus COVID - 19 stroke management risk factors

References (37)

  1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
  2. 2 Endothelial cell infection and endotheliitis in COVID-19 [DOI]
  3. 3 Progress and challenges in translating the biology of atherosclerosis [DOI]
  4. 4 Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 [DOI]
  5. 5 Cardiovascular disease and COVID-19 [DOI]
  6. 6 Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study [DOI]
  7. 7 Global brain inflammation in stroke [DOI]
  8. 8 Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza [DOI]
  9. 9 SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS [DOI]
  10. 10 SARS-CoV-2 and Stroke in a New York Healthcare System [DOI]
  11. 11 The Coronavirus Disease 2019 (COVID-19) [DOI]
  12. 12 Diabetes & metabolic syndrome : clinical research & reviews
  13. 13 Virus Infections in the Nervous System [DOI]
  14. 14 Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series [DOI]
  15. 15 Inflammation and Infections as Risk Factors for Ischemic Stroke [DOI]
  16. 16 Isolated Sudden Onset Anosmia in COVID-19 Infection. A Novel Syndrome? [DOI]
  17. 17 Within the Brain: The Renin Angiotensin System [DOI]
  18. 18 Angiotensin‐converting enzyme 2 in the brain: properties and future directions [DOI]
  19. 19 COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature [DOI]
  20. 20 Neuroinvasive and Neurotropic Human Respiratory Coronaviruses: Potential Neurovirulent Agents in Humans [DOI]
  21. 21 Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry [DOI]
  22. 22 Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients [DOI]
  23. 23 Anti-inflammatory approaches to ischaemic stroke prevention [DOI]
  24. 24 Current Epidemiological and Clinical Features of COVID-19; a Global Perspective From China [DOI]
  25. 25 COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center [DOI]
  26. 26 Elevated Levels of Circulating Cell Adhesion Molecules in Uncomplicated Essential Hypertension [DOI]
  27. 27 Consensus statement – suggested recommendations for acute stroke management during the COVID-19 pandemic: Expert group on behalf of the indian stroke association [DOI]
  28. 28 COVID-19 and \ stroke: Incidental, triggered or causative [DOI]
  29. 29 Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control study [DOI]
  30. 30 Infectious causes of stroke [DOI]
  31. 31 Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension [DOI]
  32. 32 La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
  33. 33 International Journal of Molecular Sciences [DOI]
  34. 34 European Journal of Clinical Investigation [DOI]
  35. 35 Journal of Stroke and Cerebrovascular Diseases [DOI]
  36. 36 Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak [DOI]
  37. 37 Incidence, Characteristics and Clinical Relevance of Acute Stroke in Old Patients Hospitalized With COVID-19 [DOI]

Cited by 1

Characteristics of Aphasia in Ischemic Stroke Patients at Dr. Mahar Mardjono National Brain Center Hospital Indonesia in 2021

Rasya Hapsari Danardhono, Arman Yurisaldi Saleh, Ria Maria Theresa · Folia Medica Indonesiana · 2023

Related research

Article metrics

Real usage data collected on this platform.

35

Page views

0

PDF downloads

2

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.